IT seems that Guyanese are not taking seriously enough the tremendous impact that overweight has on the two main non-communicable diseases (NCDs)primarily responsible for deaths in this country – ...

Every year, World Obesity Day brings back the same question: Is weight the real enemy? For years, body weight and BMI have dominated health charts. Bu.

World Obesity Day on Wednesday is drawing attention to a problem a Polish specialist says affects millions, with serious ...

The full spectrum of metabolic disorders, typically seen in older adults, is increasingly affecting children in India, and this includes being overweight or obese ...

Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity medicine. The parallels between weight loss and erectile dysfunction — two ...

Hims & Hers Health shares jumped sharply on Monday following reports that Novo Nordisk may distribute its obesity drugs to HIMS through t ...

Childhood obesity isn't always visible hidden risks demand early detection and healthy habits.

The ever-eccentric (to put it kindly) US secretary of health Robert F Kennedy Jr. earlier this month unveiled his ‘upside-down’ food pyramid, which reverses much of the conventional dietary wisdom of ...

Childhood obesity is a growing health concern worldwide, affecting millions of children every year. It occurs when a child’s weight is higher than what is healthy for their age and height. Excess ...

Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.

Pfizer (NYSE:PFE) is stepping deeper into the global weight loss race, striking a deal with Hangzhou Sciwind Bioscience for exclusive commercialization rights to ecnoglutide in mainland China, in an ...

Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the fast-growing weight loss market.